J Cancer 2022; 13(15):3711-3712. doi:10.7150/jca.80450 This issue Cite
Erratum
1. Pharmacy Department, Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences; Cancer Hospital of the University of Chinese Academy of Sciences; Zhejiang Cancer Hospital, Hangzhou 310022, People's Republic of China.
2. Neurotumor surgery department, Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences; Cancer Hospital of the University of Chinese Academy of Sciences; Zhejiang Cancer Hospital, Hangzhou 310022, People's Republic of China.
3. Cancer Institute department, Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences; Cancer Hospital of the University of Chinese Academy of Sciences; Zhejiang Cancer Hospital, Hangzhou 310022, People's Republic of China.
4. Department of pharmacy, ZheJiang Chinese Medicine and Western Medicine Integrated Hospital, 310003, Hangzhou, Zhejiang, P. R. China.
#Co-first authors.
Corrected-article in J Cancer, Volume 11, 4810
Recently, we conducted an examination of our published articles and found that a representative picture (Figure 6E) was incorrect, and the error was made during the assembly of the picture. Below is the corrected figure 6.
Apoptosis detection in primary cultured human glioma cells. A. Control B. Borneol 10 µg/ml C. Borneol 20 µg/ml D. Borneol 40 µg/ml E. Borneol 80 µg/ml comparison with the control group, ▲ P<0.05, ▲▲ P <0.01.
Corresponding authors: Guonong Yang. Department of Pharmacy, Zhejiang Cancer Hospital, NO.1 East Banshan Road, Gongshu District, Hangzhou 310022, P.R. China, Tel: 86-571-88122120, E-mail: yanggnorg.cn; Xinjun Cai. Department of Pharmacy, ZheJiang Chinese Medicine and Western Medicine Integrated Hospital, 310003, Hangzhou, Zhejiang, P. R. China, Tel: 86-571-56109869, E-mail: zjtcmcxjcom.
Published 2022-12-30